Last reviewed · How we verify

NCT07443917

Prevalence of Treponema Parvum in Subgingival Microbiome of Patients With Periodontitis

Recruiting now Last updated 2 March 2026
What this trial tests

trial in Periodontitis in 112 participants. Currently enrolling.

Timeline
1 December 2025
Primary endpoint
1 June 2026
1 September 2026

Quick facts

Lead sponsorUniversity of Baghdad
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment112
Start date1 December 2025
Primary completion1 June 2026
Estimated completion1 September 2026
Sites1 location across Iraq

Conditions studied

Sponsor

University of Baghdad

Who can join

30 and older, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study primarily aims to evaluate the presence of T. parvum in periodontal health and disease, and its correlation with clinical parameters. Subgingival plaque samples will be collected using sterile paper points then the samples will be analyzed using quantitative polymerase chain reaction (qPCR) to detect T. parvum and estimate its relative amount in the biofilm. The results may help clarify the association between T. parvum and periodontitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other University of Baghdad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07443917.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing